Poland· PL-100196626

Imovax Polio

A poliomyelitis, trivalent, inaktiviert, ganzes virus product containing vaccinum poliomyelitidis inactivatum szczepionka przeciw poliomyelitis, inaktywowana, registered in Poland by Sanofi Winthrop Industrie. The same ATC class is registered in 8 of our 19 countries.

ATC J07BF03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedImovax PolioATCJ07BF03REGISTER NO.PL-100196626PACKS LISTED7CHECKEDSeptember 27, 2026

Where it is registered

Poliomyelitis, trivalent, inaktiviert, ganzes virus is registered in 8 of 19 countries.

Countries holding a registration under ATC J07BF03 (poliomyelitis, trivalent, inaktiviert, ganzes virus), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Poliomyelitis, trivalent, inaktiviert, ganzes virus · ATC J07BF03

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Vaccinum poliomyelitidis inactivatum Szczepionka przeciw poliomyelitis, inaktywowana
Manufacturer
Sanofi Winthrop Industrie
Country
Poland (PL)
ATC code
J07BF03
ATC class
Poliomyelitis, trivalent, inaktiviert, ganzes Virus
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909990050215
  • gtin
    05909990050222
  • gtin
    05909990050239
  • gtin
    03664798023220
  • gtin
    05909990050246
  • gtin
    05909990616497
  • gtin
    05909990616503

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b0195e86-4865-4eb5-a6f9-7186e9ae36a3
GET /v1/drugs/b0195e86-4865-4eb5-a6f9-7186e9ae36a3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina do wstrzykiwań w ampułko-strzykawce",
  "source": "urpl",
  "strength": "29 jednostek antygenu D wirusa poliomyelitis typ 1, szczep Mahoney, 7 jednostek antygenu D wirusa poliomyelitis typ 2, szczep MEF-1 i 26 jednostek antygenu D wirusa poliomyelitis typ 3, szczep Saukett/0,5 ml; Szczepionka 1-dawkowa, 1 dawka (0,5 ml)",
  "packaging": "05909990050215 ¦ Rp ¦ Skasowane ¦ 4859\n1 amp.-strzyk. 0,5 ml\n05909990050222 ¦ Rp ¦ Skasowane ¦ 4868\n20 amp.-strzyk. 0,5 ml\n05909990050239 ¦ Rp ¦ 20810\n1 amp.-strzyk. 0,5 ml z igłą\n¦ UR/Z/4c/072/25 - 03664798023220\n05909990050246 ¦ Rp ¦ 20811\n20 amp.-strzyk. 0,5 ml z igłą\n05909990616497 ¦ Rp ¦ 34306\n1 amp.-strzyk. 0,5 ml ¦ 1 igła \n05909990616503 ¦ Rp ¦ 34307\n1 amp.-strzyk. 0,5 ml ¦ 2 igły",
  "substance": "Wirus poliomyelitis typ 1, szczep Mahoney (inaktywowany) 29 jednostek antygenu D + Vaccinum poliomyelitidis inactivum 0.5 ml + Wirus poliomyelitis typ 2, szczep MEF-1 (inaktywowany) 7 jednostek antygenu D + Wirus poliomyelitis typ 3, szczep Saukett (inaktywowany) 26 jednostek antygenu D",
  "common_name": "Vaccinum poliomyelitidis inactivatum Szczepionka przeciw poliomyelitis, inaktywowana",
  "pl_product_id": "100196626",
  "pozwolenie_nr": "00502",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about poliomyelitis, trivalent, inaktiviert, ganzes virus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.